GSK launches gynecological cancer initiative after survey reveals care gaps

There is a significant gap in patients’ understanding of treatment options for gynecologic cancers, according to a survey conducted by The Harris Poll on behalf of GSK.

In a poll of more than 800 gynecologic cancer patients across 10 countries, 80% said they face significant barriers to care, such as making appointments and accessing appropriate treatments in a timely fashion.